Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation

NCT02695277 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT02695277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02695277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
September 30, 2024
Enrollment
146 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, persistent and longstanding persistent atrial fibrillation